ライフサイエンスコーパス: there are

1 ated with therapeutics targeting the IL-1 pathway; however, there are a number of identified CAPS patients who show only

2 for RNA Polymerase II, CBP, and architectural proteins but there are also distinctions.

3 However, there are complications in the use of organic chromophores ar

4 However, there are conflicting perspectives on the roles of mosaicism

5 t how LMP1 expression is regulated in epithelial cells, and there are conflicting reports about whether it plays any role

6 th factor (VEGF)-A has been implicated in this context, but there are conflicting reports as to whether it is a contribut

7 However, there are considerable challenges in analyzing large-scale mo

8 Because there are currently no biological treatments for hearing loss

9 Furthermore, there are currently no validated biomarkers that predict whic

10 In conclusion, there are distinct distribution patterns of circumferential a

11 Although there are distinct ocular advantages to anti-VEGF pharmacothe

12 al studies of many different histone chaperones reveal that there are few commonalities in their folds.

13 Although psoriasis has been associated with obesity, there are few prospective studies with objective measures.

14 tients who are ineligible for revascularization procedures, there are few therapeutic alternatives, leading to amputation

15 all into either the high or low gene flux modes, suggesting there are genetic as well as ecological drivers of horizontal

16 In addition, there are geographic influences on the present genomic divers

17 es against V3 can interfere with the induction of NAbs, but there are good arguments in favor of suppressing such "off-ta

18 The question thus arises whether there are instances where the quantum time evolution of a mac

19 However, there are many gastrointestinal and hepatic diseases for whic

20 While there are much data to support the role of transcriptional re

21 However, there are multiple problems associated with polymer based app

22 Over the entire dose range, there are negative mortality dose trends for all circulatory

23 Currently, there are no approaches to assess the rheological properties

24 However, beyond BRCA1/2 mutations, there are no approved biomarkers for olaparib in high-grade s

25 To date, there are no AR variant-specific treatments for CRPC.

26 However, to date, there are no commercially available devices able to obtain ul

27 en patient-provider communication and medication adherence, there are no empirical data on how the informational and rela

28 eatment options against MERS-CoV for humans or animals, and there are no large-scale clinical trials for therapies agains

29 e potential to advance rational vaccine development but yet there are no licensed vaccines against malaria based on antig

30 To our knowledge, there are no published recommendations on the medical managem

31 a in the biofilm form to antimicrobial decontamination, and there are no quantitative models to study how biofilm might b

32 Observational data in this area are conflicting, and there are no randomized clinical trials to guide practitioner

33 mal recessive mutations in the gene UBE3B However, to date, there are no studies that have determined the cellular or enz

34 re important technological parameters for whose measurement there are not accepted procedures.

35 However, in the literature there are not works dealing with the quantitative application

36 Although there are numerous devices developed to isolate individual ci

37 Yet there are only a handful of studies demonstrating control of

38 Multi-antigen vaccines are under development, and there are presently far more candidate antigens than antigen

39 nals received by the vibrissae of a live seal and show that there are prominent signals at frequencies where the seal tac

40 However, there are several additional diagnoses that should be conside

41 In cardiac myocytes, there are several Ca(2+) -sensitive potassium (K(+) ) current

42 Despite sequence conservation, there are significant structural differences between microtub

43 However, there are situations where connectivity exists without a nurs

44 the fact that there is rapidly accruing literature on CBCT, there are still no current evidence-based guidelines on its n

45 the first steps toward potential therapies have been taken, there are substantial obstacles that will need to be overcome

46 Because of the nature of the ARG, there are two distinct features related to the waveguide: i)

47 It is widely documented that there are two types of neglect: egocentric neglect (neglect o

48 W. smithii provides a unique starting point to determine if there are universal nonbiting genes in mosquitoes that could

49 the main reason for breast cancer-associated mortality, and there are unmet clinical demands for the discovery of new bio

50 At the same time, their enormous evolutionary diversity (there are yeast species in every subphylum of Dikarya) sparke